Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 6
Submit an article Journal homepage
242
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

MUC4 expression by immunohistochemistry is a specific marker for BCR-ABL1+ and BCR-ABL1-like B-lymphoblastic leukemia

Benjamin Kaumeyera Department of Pathology, University of Chicago, Chicago, IL, USA
,
Shiraz Fidaia Department of Pathology, University of Chicago, Chicago, IL, USA;b Department of Pathology and Laboratory Medicine, John H. Stroger Hospital of Cook County, Chicago, IL, USA
,
Madina Sukhanovac Department of Medicine. University of Chicago, Chicago, IL, USA;d Department of Pathology & Laboratory Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
,
Kai Lee Yapc Department of Medicine. University of Chicago, Chicago, IL, USA;e Department of Pathology & Laboratory Medicine, Ann & Robert H. Lurie Children’s Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
,
Jeremy Segala Department of Pathology, University of Chicago, Chicago, IL, USA
,
Gordana Racac Department of Medicine. University of Chicago, Chicago, IL, USA;f Department of Pathology and Laboratory Medicine, Children’s Hospital Los Angeles, Keck School of Medicine, University of Southern California, California, LA, USA
,
Wendy Stockc Department of Medicine. University of Chicago, Chicago, IL, USA
,
Jennifer McNeerg Department of Pediatrics, University of Chicago, Chicago, IL, USA
,
Angela M. Lagerc Department of Medicine. University of Chicago, Chicago, IL, USA
&
Sandeep Gurbuxania Department of Pathology, University of Chicago, Chicago, IL, USACorrespondence[email protected]
 show all
Pages 1436-1444 | Received 21 Nov 2021, Accepted 30 Dec 2021, Published online: 16 Feb 2022

References

  • Schwab C, Harrison CJ. Advances in B-cell precursor acute lymphoblastic leukemia genomics. Hemasphere. 2018;2(4):e53.
  • Fielding AK. Curing Ph + ALL: assessing the relative contributions of chemotherapy, TKIs, and allogeneic stem cell transplant. Hematol Am Soc Hematol Educ Program. 2019;2019(1):24–29.
  • Den Boer ML, van Slegtenhorst M, De Menezes RX, et al. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol. 2009;10(2):125–134.
  • Mullighan CG, Su X, Zhang J, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med. 2009;360(5):470–480.
  • Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405.
  • Chiaretti S, Messina M, Foà R. BCR/ABL1-like acute lymphoblastic leukemia: how to diagnose and treat? Cancer. 2019;125(2):194–204.
  • Roberts KG, Morin RD, Zhang J, et al. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell. 2012;22(2):153–166.
  • Juric D, Lacayo NJ, Ramsey MC, et al. Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias. J Clin Oncol. 2007;25(11):1341–1349.
  • Borowitz MJ, Chan JKC, Downing J, et al. Precursor lymphoid neoplasms. In: Swerdlow SH, Campo E, Harris NL, editors. WHO classification of tumors of hematopoietic and lymphoid tissues. 4th ed. Lyon, France: International Agency for Research on Cancer; 2017.
  • Kadri S, Long BC, Mujacic I, et al. Clinical validation of a Next-Generation sequencing genomic oncology panel via Cross-Platform benchmarking against established amplicon sequencing assays. J Mol Diagn. 2017;19(1):43–56.
  • Konoplev S, Lu X, Konopleva M, et al. CRLF2-Positive B-Cell acute lymphoblastic leukemia in adult patients: a Single-Institution experience. Am J Clin Pathol. 2017;147(4):357–363.
  • Roberts KG, Li Y, Payne-Turner D, et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med. 2014;371(11):1005–1015.
  • Soverini S, Hochhaus A, Nicolini FE, et al. BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet. Blood. 2011;118(5):1208–1215.
  • Soverini S, Branford S, Nicolini FE, et al. Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia. Leuk Res. 2014;38(1):10–20.
  • Yoda A, Yoda Y, Chiaretti S, et al. Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia. Proc Natl Acad Sci USA. 2010;107(1):252–257.
  • Kufe DW. Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer. 2009;9(12):874–885.
  • Stroopinsky D, Kufe D, Avigan D. MUC1 in hematological malignancies. Leuk Lymphoma. 2016;57(11):2489–2498.
  • Sadras T, Heatley SL, Kok CH, et al. Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesions. Cancer Lett. 2017;408:92–101.
  • Kawano T, Ito M, Raina D, et al. MUC1 oncoprotein regulates Bcr-Abl stability and pathogenesis in chronic myelogenous leukemia cells. Cancer Res. 2007;67(24):11576–11584.
  • Yap KL, Furtado LV, Kiyotani K, et al. Diagnostic evaluation of RNA sequencing for the detection of genetic abnormalities associated with Ph-like acute lymphoblastic leukemia (ALL). Leuk Lymphoma. 2017;58(4):950–958.
  • Mcneer J, Raca G, Gurbuxani S, et al. Use of chromosomal microarray analysis (CMA) to identify targetable mutations in acute lymphoblastic leukemia. Blood. 2014;124(21):5349–5349.
  • Raca G, Gurbuxani S, Zhang Z, et al. RCSD1-ABL2 fusion resulting from a complex chromosomal rearrangement in high-risk B-cell acute lymphoblastic leukemia. Leuk Lymphoma. 2015;56(4):1145–1147.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.